Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

Clinical trial NCT06505551 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06505551
Sponsor: SCG Cell Therapy Pte. Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HPV-Related Squamous Cell Carcinoma HPV-Related Cervical Squamous Cell Carcinoma HPV-Related Vulvar Squamous Cell Carcinoma HPV-Related Penile Squamous Cell Carcinoma HPV-Related Vaginal Squamous Cell Carcinoma HPV-Related Anal Squamous Cell Carcinoma HPV-Related Head and Neck Cancer

Start date: 2024-10-01
Primary completion: 2026-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.